Small Molecules
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
185
NCT05226507
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 31, 2021
Completion: Dec 31, 2025
NCT05873686
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Start: Oct 26, 2023
Completion: Jul 31, 2027
Loading map...